학술논문

Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Document Type
Article
Source
In Annals of Oncology June 2021 32(6):757-765
Subject
Gynecological tumors
Language
ISSN
0923-7534